Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 891-902

  Jenner, R G ^a   Alba M M ^a   Boshoff, C ^a   Kellam, P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NYLON; VIRUS DNA;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CELL CYCLE; CELL LINE; GENE CLUSTER; GENE EXPRESSION; GENE FUNCTION; HUMAN HERPESVIRUS 8; IMMUNOMODULATION; KAPOSI SARCOMA; LYMPHOMA; LYSIS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS LATENCY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CELL LINE; CLUSTER ANALYSIS; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HERPESVIRUS 8, HUMAN; HUMANS; INTERFERON REGULATORY FACTORS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; TRANSCRIPTION FACTORS; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0035167125     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.891-902.2001     Document Type: Article

References (52)

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
2. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus
3. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
4. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines
5. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300
6. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2)
7. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
8. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
9. DNA microarrays of the complex human cytomegalovirus genome: Profiling kinetic class with drug sensitivity of viral gene expression
10. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
11. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome
12. The transcriptional program of sporulation in budding yeast
13. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients
14. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
15. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors
16. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma
17. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
18. Cluster analysis and display of genome-wide expression patterns
19. The BFRF1 gene of Epstein-Barr virus encodes a novel protein
20. p53 inhibition by the LANA protein of KSHV protects against cell death
21. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays
22. Identification of a spliced gene from Kaposi's sarcoma-associated herpesvims encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus
23. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease
24. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection
25. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen
26. Genomics, gene expression and DNA arrays
27. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors
28. Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates
29. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells
30. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
31. Antiviral activity of tumor-suppressor pathways: Clues from molecular piracy by KSHV
32. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity?
33. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and together with the oncogene hras transforming primary rat cells
34. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
35. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
36. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus
37. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
38. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue
39. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter
40. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
41. Kaposi's sarcoma-associated herpesvirus: From cell biology to pathogenesis
42. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
43. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
44. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression
45. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line
46. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
47. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
48. Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
49. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma
50. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus
51. Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays
52. Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: Characterization of antiherpesvirus agents